1980
DOI: 10.1111/j.1365-2125.1980.tb01809.x
|View full text |Cite
|
Sign up to set email alerts
|

Potential therapeutic applications of aspirin and other cyclo‐oxygenase inhibitors.

Abstract: 1 The ubiquitous actions of the cyclo‐oxygenase inhibitors are described. 2 These include the inhibitory effect on prostaglandin synthesis and the direct effect of aspirin on lymphocytes and their ability to produce lymphokines. 3 Aspirin reduces some types of platelet aggregation possibly involving inhibition of the precursors of thromboxane A2 and prostacyclin. 4 The therapeutic implications in relation to transient ischaemic attacks, coronary artery disease and reno‐allograft rejection are discussed. 5 The … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

1982
1982
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 162 publications
0
6
0
Order By: Relevance
“…This differential effect could reflect the known irreversible effect of acetylsalicylic acid on platelet TXA2 synthesis. Platelets have a life span of about 10 days (Farah & Rosenberg, 1980) in contrast to the approximately daily turnover of prostacyclin (Jaffe & Weksler, 1979).…”
Section: Discussionmentioning
confidence: 99%
“…This differential effect could reflect the known irreversible effect of acetylsalicylic acid on platelet TXA2 synthesis. Platelets have a life span of about 10 days (Farah & Rosenberg, 1980) in contrast to the approximately daily turnover of prostacyclin (Jaffe & Weksler, 1979).…”
Section: Discussionmentioning
confidence: 99%
“…Although the precise mechanism for this cancer preventive activity is not clear, it is believed that it occurs through inhibition of COX enzymes (both COX-1 and -2) and the prevention of the synthesis of prostaglandins and other metabolites associated with inflammation and carcinogenesis [38][39][40][41]. Alternative mechanisms to COX inhibition that need further exploration have been postulated recently.…”
Section: Nsaidsmentioning
confidence: 99%
“…Statistical analyses were performed using the two-tailed Fisher exact probability test for incidence, the Kruskal-Wallis nonparametric test with Dunn's multiple comparison test for EAE severity (mean scores) and body weight. The unpaired Student's (10,20, and 30 μL or 0.5, 1.0, 1.5 g/kg) of homosalate or octisalate topically. The mean score was recorded.…”
Section: Methodsmentioning
confidence: 99%